Third EU endocrine chemical strategy review out

Progress report says 51 substances on priority evaluation list are not regulated at EU level

A six-year investigation into endocrine-disrupting chemicals (EDCs) has discovered over fifty potentially problematic substances that are not being regulated at EU level, according to the latest review of a strategy launched in 1999 (EED 21/12/99) (EED 12/11/04).

The third review of the EU EDCs strategy is published by the European commission and covers the three years to the end of 2006. By then the commission's priority list of EDCs under investigation amounted to 428 substances.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.